D

Dx & Vx Co Ltd
KOSDAQ:180400

Watchlist Manager
Dx & Vx Co Ltd
KOSDAQ:180400
Watchlist
Price: 7 740 KRW -4.33% Market Closed
Market Cap: 154.5B KRW

Dx & Vx Co Ltd
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Dx & Vx Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
D
Dx & Vx Co Ltd
KOSDAQ:180400
Operating Income
-â‚©56.7B
CAGR 3-Years
-187%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Operating Income
â‚©889.7B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
15%
P
PharmaResearch Co Ltd
KOSDAQ:214450
Operating Income
â‚©169.2B
CAGR 3-Years
43%
CAGR 5-Years
50%
CAGR 10-Years
28%
Alteogen Inc
KOSDAQ:196170
Operating Income
â‚©75.5B
CAGR 3-Years
N/A
CAGR 5-Years
59%
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Operating Income
-â‚©22.1B
CAGR 3-Years
23%
CAGR 5-Years
7%
CAGR 10-Years
N/A
D
DND PharmaTech Inc
KOSDAQ:347850
Operating Income
-â‚©25B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Dx & Vx Co Ltd
Glance View

Market Cap
154.5B KRW
Industry
Biotechnology

Dx & Vx Co., Ltd. engages in the development of molecular diagnostic products. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-12-15. The Molecular Diagnosis Business segment is engaged in the manufacture and sale of deoxyribonucleic acid (DNA) chips, polymerase chain reaction (PCR) chips and other products. manufacture and sale of diagnostic reagents used for molecular diagnosis, and various enzymes and experimental reagents used for biological research.

Intrinsic Value
6 120.97 KRW
Overvaluation 21%
Intrinsic Value
Price
D

See Also

What is Dx & Vx Co Ltd's Operating Income?
Operating Income
-56.7B KRW

Based on the financial report for Jun 30, 2025, Dx & Vx Co Ltd's Operating Income amounts to -56.7B KRW.

What is Dx & Vx Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-56%

Over the last year, the Operating Income growth was -303%. The average annual Operating Income growth rates for Dx & Vx Co Ltd have been -187% over the past three years , -56% over the past five years .

Back to Top